Single-domain antibody fragments derived from heavy-chain antibodies: A review

Veterinarni Medicina

Volumn 57, Issue 9, 2012, Pages 439-513

  Eyer, Ludek ^a   Hruska, K ^a  

^a VETERINARY RESEARCH INSTITUTE   (Czech Republic)

Author keywords

Antigen binding site; Camelid; Heavy chain antibody; Recombinant technology; Shark; Single domain antibody fragment; Therapy

Indexed keywords

ARTIODACTYLA; CAMELIDAE; CHONDRICHTHYES;

EID: 84869457685     PISSN: 03758427     EISSN: None     Source Type: Journal    
DOI: 10.17221/6336-VETMED     Document Type: Review

References (161)

1. Abskharon RNN, Soror SH, Pardon E, El Hassan H, Legname G, Steyaert J, Wohlkonig A (2011): Combining in-situ proteolysis and microseed matrix screening to promote crystallization of PrP(c)-nanobody complexes. Protein Engineering Design and Selection 24, 737-741
2. Abulrob A, Sprong H, Henegouwen PVBE, Stanimirovic D (2005): The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. Journal of Neurochemistry 95, 1201-1214
3. Aladin F, Einerhand AWC, Bouma J, Bezemer S, Hermans P, Wolvers D, Bellamy K, Frenken LGJ, Gray J, Iturriza-Gomara M (2012): In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. Plos One 7
4. Altintas I, Kok RJ, Schiffelers RM (2012): Targeting epidermal growth factor receptor in tumors: From conventional monoclonal antibodies via heavy chainonly antibodies to nanobodies. European Journal of Pharmaceutical Sciences 45, 399-407
5. Alvarez-Rueda N, Behar G, Ferre V, Pugniere M, Roquet F, Gastinel L, Jacquot C, Aubry J, Baty D, Barbet J, Birkle S (2007): Generation of llama single-domain antibodies against methotrexate, a prototypical hapten. Molecular Immunology 44, 1680-1690
6. Alzogaray V, Danquah W, Aguirre A, Urrutia M, Berguer P, Vescovi EG, Haag F, Koch-Nolte F, Goldbaum FA (2011): Single-domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium. Faseb Journal 25, 526-534
7. Anderson GP, Bernstein RD, Swain MD, Zabetakis D, Goldman ER (2010): Binding kinetics of antiricin single domain antibodies and improved detection using a B chain specific binder. Analytical Chemistry 82, 7202-7207
8. Anderson GP, Goldman ER (2008): TNT detection using llama antibodies and a two-step competitive fluid array immunoassay. Journal of Immunological Methods 339, 47-54
9. Baral TN, Magez S, Stijlemans B, Conrath K, Vanhollebeke B, Pays E, Muyldermans S, De Baetselier P (2006): Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor. Nature Medicine 12, 580-584
10. Baral TN, Murad Y, Nguyen TD, Iqbal U, Zhang JB (2011): Isolation of functional single domain antibody by whole cell immunization: Implications for cancer treatment. Journal of Immunological Methods 371, 70-80
11. Bazl MR, Rasaee MJ, Foruzandeh M, Rahimpour A, Kiani J, Rahbarizadeh F, Alirezapour B, Mohammadi M (2007): Production of chimeric recombinant single domain antibody-green fluorescent fusion protein in Chinese hamster ovary cells. Hybridoma 26, 1-9
12. Behdani M, Zeinali S, Khanahmad H, Karimipour M, Asadzadeh N, Azadmanesh K, Khabiri A, Schoonooghe S, Anbouhi MH, Hassanzadeh-Ghassabeh G, Muyldermans S (2012): Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor. Molecular Immunology 50, 35-41
13. Bell A, Wang ZJ, Arbabi-Ghahroudi M, Chang TTA, Durocher Y, Trojahn U, Baardsnes J, Jaramillo ML, Li SH, Baral TN, O'Connor-McCourt M, MacKenzie R, Zhang JB (2010): Differential tumor-targeting abilities of three single-domain antibody formats. Cancer Letters 289, 81-90
14. Ben Abderrazek R, Vincke C, Hmila I, Saerens D, Abidi N, El Ayeb M, Muyldermans S, Bouhaouala-Zahar B (2011): Development of Cys38 knock-out and humanized version of NbAahII10 nanobody with improved neutralization of AahII Scorpion toxin. Protein Engineering Design and Selection 24, 727-735
15. Blanco-Toribio A, Muyldermans S, Frankel G, Fernandez LA (2010): Direct injection of functional single-domain antibodies from E. coli into human cells. Plos One 5
16. Broisat A, Hernot S, Toczek J, De Vos J, Riou LM, Martin S, Ahmadi M, Thielens N, Wernery U, Caveliers V, Muyldermans S, Lahoutte T, Fagret D, Ghezzi C, Devoogdt N (2012): Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions. Circulation Research 110, 927-937
17. Caljon G, Caveliers V, Lahoutte T, Stijlemans B, Ghassabeh GH, Van Den Abbeele J, Smolders I, De Baetselier P, Michotte Y, Muyldermans S, Magez S, Clinckers R (2012): Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier. British Journal of Pharmacology 165, 2341-2353
18. Caussinus E, Kanca O, Affolter M (2012): Fluorescent fusion protein knockout mediated by anti-GFP nanobody. Nature Structural and Molecular Biology 19, 117-121
19. Conrad U, Plagmann I, Malchow S, Sack M, Floss DM, Kruglov AA, Nedospasov SA, Rose-John S, Scheller J (2011): ELPylated anti-human TNF therapeutic singledomain antibodies for prevention of lethal septic shock. Plant Biotechnology Journal 9, 22-31
20. Conrath KE, Wernery U, Muyldermans S, Nguyen VK (2003): Emergence and evolution of functional heavychain antibodies in Camelidae. Developmental and Comparative Immunology 27, 87-103
21. Conrath K, Vincke C, Stijlemans B, Schymkowitz J, Decanniere K, Wyns L, Muyldermans S, Loris R (2005): Antigen binding and solubility effects upon veneering of a camel VHH in framework-2 to the mimic a VH. Journal of Molecular Biology 350, 112-125
22. Conway JO, Sherwood LJ, Collazo MT, Garza JA, Hayhurst A (2010): Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents. Plos One 5
23. Cortez-Retamozo V, Lauwereys M, Gh GH, Gobert M, Conrath K, Muyldermans S, De Baetselier P, Revets H (2002): Efficient tumor targeting by single-domain antibody fragments of camels. International Journal of Cancer 98, 456-462
24. Cortez-Retamozo V, Backmann N, Senter PD, Wernery U, De Baetselier P, Muyldermans S, Revets H (2004): Efficient cancer therapy with a nanobody-based conjugate. Cancer Research 64, 2853-2857
25. Daley LP, Kutzler MA, Bennett BW, Smith MC, Glaser AL, Appleton JA (2010): Effector functions of camelid heavy-chain antibodies in immunity to West Nile virus. Clinical and Vaccine Immunology 17, 239-246
26. De Genst E, Silence K, Decanniere K, Conrath K, Loris R, Kinne R, Muyldermans S, Wyns L (2006): Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proceedings of the National Academy of Sciences of the United States of America 103, 4586-4591
27. De Genst EJ, Guilliams T, Wellens J, O'Day EM, Waudby CA, Meehan S, Dumoulin M, Hsu STD, Cremades N, Verschueren KHG, Pardon E, Wyns L, Steyaert J, Christodoulou J, Dobson CM (2010): Structure and properties of a complex of alpha-synuclein and a single-domain camelid antibody. Journal of Molecular Biology 402, 326-343
28. de Marco A (2011): Biotechnological applications of recombinant single-domain antibody fragments. Microbial Cell Factories 10, 44
29. De Marni ML, Monegal A, Venturini S, Vinati S, Carbone R, de Marco A (2012): Antibody purification-independent microarrays (PIM) by direct bacteria spotting on TiO2-treated slides. Methods 56, 317-325
30. De Vooght L, Caljon G, Stijlemans B, De Baetselier P, Coosemans M, Van Den Abbeele J (2012): Expression and extracellular release of a functional anti-trypanosome Nanobody (R) in Sodalis glossinidius, a bacterial symbiont of the tsetse fly. Microbial Cell Factories 11, 23
31. Decanniere K, Desmyter A, Lauwereys M, Ghahroudi MA, Muyldermans S, Wyns L (1999): A single-domain antibody fragment in complex with RNase A: noncanonical loop structures and nanomolar affinity using two CDR loops. Structure with Folding and Design 7, 361-370
32. Deckers N, Saerens D, Kanobana K, Conrath K, Victor B, Wernery U, Vercruysse J, Muyldermans S, Dorny P (2009): Nanobodies, a promising tool for speciesspecific diagnosis of Taenia solium cysticercosis. International Journal for Parasitology 39, 625-633
33. Deffar K, Shi HL, Li L, Wang XZ, Zhu XJ (2009): Nanobodies-the new concept in antibody engineering. African Journal of Biotechnology 8, 2645-2652
34. Delanote V, Vanloo B, Catillon M, Friederich E, Vandekerckhove J, Gettemans J (2010): An alpaca singledomain antibody blocks filopodia formation by obstructing L-plastin-mediated F-actin bundling. Faseb Journal 24, 105-118
35. Dolk E, van der Vaart M, Hulsik DL, Vriend G, de Haard H, Spinelli S, Cambillau C, Frenken L, Verrips T (2005a): Isolation of llama antibody fragments for prevention of dandruffby phage display in shampoo. Applied and Environmental Microbiology 71, 442-450
36. Dolk E, van Vliet C, Perez JMJ, Vriend G, Darbon H, Ferrat G, Cambillau C, Frenken LGJ, Verrips T (2005b): Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen. Proteins-Structure Function and Bioinformatics 59, 555-564
37. Domanska K, Vanderhaegen S, Srinivasan V, Pardon E, Dupeux F, Marquez JA, Giorgetti S, Stoppini M, Wyns L, Bellotti V, Steyaert J (2011): Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta 2-microglobulin variant. Proceedings of the National Academy of Sciences of the United States of America 108, 1314-1319
38. Dona V, Urrutia M, Bayardo M, Alzogaray V, Goldbaum FA, Chirdo FG (2010): Single domain antibodies are specially suited for quantitative determination of gliadins under denaturing conditions. Journal of Agricultural and Food Chemistry 58, 918-926
39. Dumoulin M, Conrath K, Van Meirhaeghe A, Meersman F, Heremans K, Frenken LGJ, Muyldermans S, Wyns L, Matagne A (2002): Single-domain antibody fragments with high conformational stability. Protein Science 11, 500-515
40. Emmerson CD, van der Vlist EJ, Braam MR, Vanlandschoot P, Merchiers P, de Haard HJW, Verrips CT, Henegouwen PMPV, Dolk E (2011): Enhancement of polymeric immunoglobulin receptor transcytosis by biparatopic VHH. Plos One 6
41. Ezzine A, el Adab SM, Bouhaouala-Zahar B, Hmila I, Baciou L, Marzouki MN (2012): Efficient expression of the anti-AahI' scorpion toxin nanobody under a new functional form in a Pichia pastoris system. Biotechnology and Applied Biochemistry 59, 15-21
42. Fanning SW, Horn JR (2011): An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop. Protein Science 20, 1196-1207
43. Fennell BJ, Darmanin-Sheehan A, Hufton SE, Calabro V, Wu L, Muller MR, Cao W, Gill D, Cunningham O, Finlay WJJ (2010): Dissection of the IgNAR V domain: Molecular scanning and orthologue database mining define novel IgNAR hallmarks and affinity maturation mechanisms. Journal of Molecular Biology 400, 155-170
44. Ferrari A, Rodriguez MM, Power P, Weill FS, De Simone EA, Gutkind G, Leoni J (2007): Immunobiological role of llama heavy-chain antibodies against a bacterial beta-lactamase. Veterinary Immunology and Immunopathology 117, 173-182
45. Flajnik MF, Deschacht N, Muyldermans S (2011): A case of convergence: Why did a simple alternative to canonical antibodies arise in sharks and camels? Plos Biology 9
46. Forsman A, Beirnaert E, Aasa-Chapman MMI, Hoorelbeke B, Hijazi K, Koh W, Tack V, Szynol A, Kelly C, McKnight A, Verrips T, de Haard H, Weiss RA (2008): Llama antibody fragments with cross-subtype human immunodeficiency virus Type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. Journal of Virology 82, 12069-12081
47. Franco EJ, Sonneson GJ, DeLegge TJ, Hofstetter H, Horn JR, Hofstetter O (2010): Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 878, 177-186
48. Gainkam LOT, Keyaerts M, Caveliers V, Devoogdt N, Vanhove C, Van Grunsven L, Muyldermans S, Lahoutte T (2011): Correlation between epidermal growth factor receptor-specific nanobody uptake and burden: A tool for noninvasive monitoring of tumor response to therapy. Molecular Imaging and Biology 13, 940-948
49. Goldman ER, Anderson GP, Bernstein RD, Swain MD (2010): Amplification of immunoassays using phagedisplayed single domain antibodies. Journal of Immunological Methods 352, 182-185
50. Goodchild SA, Dooley H, Schoepp RJ, Flajnik M, Lonsdale SG (2011): Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries. Molecular Immunology 48, 2027-2037
51. Gorlani A, Hulsik DL, Adams H, Vriend G, Hermans P, Verrips T (2012): Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae. Protein Engineering Design and Selection 25, 39-46
52. Govaert J, Pellis M, Deschacht N, Vincke C, Conrath K, Muyldermans S, Saerens D (2012): Dual beneficial effect of interloop disulfide bond for single domain antibody fragments. Journal of Biological Chemistry 287, 1970-1979
53. Graef RR, Anderson GP, Doyle KA, Zabetakis D, Sutton FN, Liu JL, Serrano-Gonzalez J, Goldman ER, Cooper LA (2011): Isolation of a highly thermal stable lama single domain antibody specific for Staphylococcus aureus Enterotoxin B. BMC Biotechnology 11
54. Greenberg AS, Avila D, Hughes M, Hughes A, Mckinney EC, Flajnik MF (1995): A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature 374, 168-173
55. Hamerscasterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R (1993): Naturally-occurring antibodies devoid of light-chains. Nature 363, 446-448
56. Harmsen MM, de Haard HJ (2007): Properties, production, and applications of camelid single-domain antibody fragments. Applied Microbiology and Biotechnology 77, 13-22
57. Harmsen MM, van Solt CB, Fijten HPD, Van Setten MC (2005): Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins. Vaccine 23, 4926-4934
58. Harmsen MM, van Solt CB, van Bemmel AMV, Niewold TA, van Zijderveld FG (2006): Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy. Applied Microbiology and Biotechnology 72, 544-551
59. Henderson KA, Streltsov VA, Coley AM, Dolezal O, Hudson PJ, Batchelor AH, Gupta A, Bai T, Murphy VJ, Anders RF, Foley M, Nuttall SD (2007): Structure of an IgNAR-AMA1 complex: Targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure 15, 1452-1466
60. Hendrickx MLV, De Winter A, Buelens K, Compernolle G, Hassanzadeh-Ghassabeh G, Muyldermans S, Gils A, Declerck PJ (2011): TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation. Journal of Thrombosis and Haemostasis 9, 2268-2277
61. Holliger P, Hudson PJ (2005): Engineered antibody fragments and the rise of single domains. Nature Biotechnology 23, 1126-1136
62. Honda Y, Kondo H, Caipang CMA, Hirono I, Aoki T (2010): cDNA cloning of the immunoglobulin heavy chain genes in banded houndshark Triakis scyllium. Fish and Shellfish Immunology 29, 854-861
63. Huang L, Muyldermans S, Saerens D (2010): Nanobodies (R): proficient tools in diagnostics. Expert Review of Molecular Diagnostics 10, 777-785
64. Hultberg A, Tremblay DM, de Haard H, Verrips T, Moineau S, Hammarstom L, Marcotte H (2007): Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages. BMC Biotechnology 7, 58
65. Hultberg A, Temperton NJ, Rosseels V, Koenders M, Gonzalez-Pajuelo M, Schepens B, Ibanez LI, Vanlandschoot P, Schillemans J, Saunders M, Weiss RA, Saelens X, Melero JA, Verrips CT, Van Gucht S, de Haard HJ (2011): Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules. Plos One 6
66. Hussack G, Luo Y, Veldhuis L, Hall JC, Tanha J, Mac-Kenzie R (2009): Multivalent anchoring and oriented display of single-domain antibodies on cellulose. Sensors 9, 5351-5367
67. Hussack G, Hirama T, Ding W, MacKenzie R, Tanha J (2011a): Engineered single-domain antibodies with high protease resistance and thermal stability. Plos One 6
68. Hussack G, Arbabi-Ghahroudi M, van Faassen H, Songer JG, Ng KKS, MacKenzie R, Tanha J (2011b): Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain. Journal of Biological Chemistry 286, 8961-8976
69. Ibanez LI, De Filette M, Hultberg A, Verrips T, Temperton N, Weiss RA, Vandevelde W, Schepens B, Vanlandschoot P, Saelens X (2011): Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. Journal of Infectious Diseases 203, 1063-1072
70. Impagliazzo A, Tepper AW, Verrips TC, Ubbink M, van der Maarel SM (2010): Structural basis for a PABPN1 aggregation-preventing antibody fragment in OPMD. Febs Letters 584, 1558-1564
71. Inoue H, Ilhara A, Takahashi H, Shimada I, Ishida I, Maeda Y (2011): Affinity transfer to a human protein by CDR3 grafting of camelid VHH. Protein Science 20, 1971-1981
72. Iqbal U, Abulrob A, Stanimirovic DB (2011): Integrated platform for brain imaging and drug delivery across the blood-brain barrier. Blood-Brain and Other Neural Barriers: Reviews and Protocols 686, 465-481
73. Iri-Sofla FJ, Rahbarizadeh F, Ahmadvand D, Rasaee MJ (2011): Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by PhiC31 integrase. Experimental Cell Research 317, 2630-2641
74. Jahnichen S, Blanchetot C, Maussang D, Gonzalez-Pajuelo M, Chow KY, Bosch L, De Vrieze S, Serruys B, Ulrichts H, Vandevelde W, Saunders M, de Haard HJ, Schols D, Leurs R, Vanlandschoot P, Verrips T, Smit MJ (2010): CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proceedings of the National Academy of Sciences of the United States of America 107, 20565-20570
75. Jamnani FR, Rahbarizadeh F, Shokrgozar MA, Ahmadvand D, Mahboudi F, Sharifzadeh Z (2012): Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells. Experimental Cell Research 318, 1112-1124
76. Joosten V, Gouka RJ, van den Hondel CAMJ, Verrips CT, Lokman BC (2005): Expression and production of llama variable heavy-chain antibody fragments (V(HH)s) by Aspergillus awamori. Applied Microbiology and Biotechnology 66, 384-392
77. Kasturirangan S, Boddapati S, Sierks MR (2010): Engineered proteolytic nanobodies reduce A beta burden and ameliorate A beta-induced cytotoxicity. Biochemistry 49, 4501-4508
78. Kim HJ, Mccoy MR, Majkova Z, Dechant JE, Gee SJ, Tabares-da Rosa S, Gonzalez-Sapienza GG, Hammock BD (2012): Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay. Analytical Chemistry 84, 1165-1171
79. Kirchhofer A, Helma J, Schmidthals K, Frauer C, Cui S, Karcher A, Pellis M, Muyldermans S, Casas-Delucchi CS, Cardoso MC, Leonhardt H, Hopfner KP, Rothbauer U (2010): Modulation of protein properties in living cells using nanobodies. Nature Structural and Molecular Biology 17, 133-138
80. Koide S (2009): Engineering of recombinant crystallization chaperones. Current Opinion in Structural Biology 19, 449-457
81. Korouzhdehy B, Dadmehr M, Piri I, Rahbarizadeh F, Solouki M (2011): Expression of biological active VHH camelid single domain antibody in transgenic tobacco. African Journal of Biotechnology 10, 4234-4241
82. Ladenson RC, Crimmins DL, Landt Y, Ladenson JH (2006): Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment. Analytical Chemistry 78, 4501-4508
83. Lafaye P, Achour I, England P, Duyckaerts C, Rougeon F (2009): Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent A beta-induced neurotoxicity and inhibit fibril formation. Molecular Immunology 46, 695-704
84. Lauwereys M, Ghahroudi MA, Desmyter A, Kinne J, Holzer W, De Genst E, Wyns L, Muyldermans S (1998): Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. Embo Journal 17, 3512-3520
85. Li JW, Xia LJ, Su YH, Liu HC, Xia XQ, Lu QX, Yang CJ, Reheman K (2012): Molecular imprint of enzyme active site by camel nanobodies rapid and efficient approach to produce abzymes with alliinase activity. Journal of Biological Chemistry 287, 13713-13721
86. Makvandi-Nejad S, Fjallman T, Arbabi-Ghahroudi M, MacKenzie CR, Hall JC (2011): Selection and expression of recombinant single domain antibodies from a hyper-immunized library against the hapten azoxystrobin. Journal of Immunological Methods 373, 8-18
87. Martin MC, Pant N, Ladero V, Gunaydin G, Andersen KK, Alvarez B, Martinez N, Alvarez MA, Hammarstrom L, Marcotte H (2011): Integrative expression system for delivery of antibody fragments by Lactobacilli. Applied and Environmental Microbiology 77, 2174-2179
88. McGonigal K, Tanha J, Palazov E, Li SH, Gueorguieva-Owens D, Pandey S (2009): Isolation and functional characterization of single domain antibody modulators of caspase-3 and apoptosis. Applied Biochemistry and Biotechnology 157, 226-236
89. Moller A, Pion E, Narayan V, Ball KL (2010): Intracellular activation of interferon regulatory factor-1 by nanobodies to the multifunctional (Mf1) domain. Journal of Biological Chemistry 285, 38348-38361
90. Murtaugh ML, Fanning SW, Sharma TM, Terry AM, Horn JR (2011): A combinatorial histidine scanning library approach to engineer highly pH-dependent protein switches. Protein Science 20, 1619-1631
91. Muyldermans S, Cambillau C, Wyns L (2001): Recognition of antigens by single domain antibody fragments: the superfluous luxury of paired domains. Trends in Biochemical Sciences 26, 230-235
92. Muyldermans S, Baral TN, Retarnozzo VC, De Baetselier P, De Genst E, Kinne J, Leonhardt H, Magez S, Nguyen VK, Revets H, Rothbauer U, Stijemans B, Tillib S, Wernery U, Wyns L, Hassanzadeh-Ghassabeh G, Saerens D (2009): Camelid immunoglobulins and nanobody technology. Veterinary Immunology and Immunopathology 128, 178-183
93. Nguyen VK, Hamers R, Wyns L, Muyldermans S (1999): Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies. Molecular Immunology 36, 515-524
94. Nguyen VK, Hamers R, Wyns L, Muyldermans S (2000): Camel heavy-chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen-binding repertoire. EMBO Journal 19, 921-930
95. Nguyen VK, Su C, Muyldermans S, van der Loo W (2002): Heavy-chain antibodies in Camelidae; a case of evolutionary innovation. Immunogenetics 54, 39-47
96. Oliveira S, Schiffelers RM, van der Veeken J, van der Meel R, Vongpromek R, Henegouwen PMPV, Storm G, Roovers RC (2010): Downregulation of EGFR by a novel multivalent nanobody-liposome platform. Journal of Controlled Release 145, 165-175
97. Omidfar K, Rasaee MJ, Kashanian S, Paknejad M, Bathaie Z (2007): Studies of thermostability in Camelus bactrianus (Bactrian camel) single-domain antibody specific for the mutant epidermal-growth-factor receptor expressed by Pichia. Biotechnology and Applied Biochemistry 46, 41-49
98. Oyen D, Srinivasan V, Steyaert J, Barlow JN (2011): Constraining enzyme conformational change by an antibody leads to hyperbolic inhibition. Journal of Molecular Biology 407, 138-148
99. Paalanen MMI, Ekokoski E, El Khattabi M, Tuominen RK, Verrips CT, Boonstra J, Blanchetot C (2011): The development of activating and inhibiting camelid VHH domains against human protein kinase C epsilon. European Journal of Pharmaceutical Sciences 42, 332-339
100. Pant N, Hultberg A, Zhao YF, Svensson L, Pan-Hammarstrom Q, Johansen K, Pouwels PH, Ruggeri FM, Hermans P, Frenken L, Boren T, Marcotte H, Hammarstrom L (2006): Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. Journal of Infectious Diseases 194, 1580-1588
101. Park YJ, Pardon E, Wu MT, Steyaert J, Hol WGJ (2012): Crystal structure of a heterodimer of editosome interaction proteins in complex with two copies of a cross-reacting nanobody. Nucleic Acids Research 40, 1828-1840
102. Pollithy A, Romer T, Lang C, Muller FD, Helma J, Leonhardt H, Rothbauer U, Schuler D (2011): Magnetosome expression of functional camelid antibody fragments (nanobodies) in Magnetospirillum gryphiswaldense. Applied and Environmental Microbiology 77, 6165-6171
103. Pooja J, Ajit S (2010): Staphylococcus aureus beta-hemolysin-neutralizing single-domain antibody isolated from phage display library of Indian desert camel. Asian Pacific Journal of Tropical Medicine 3, 1-7
104. Ratier L, Urrutia M, Paris G, Zarebski L, Frasch AC, Goldbaum FA (2008): Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies. Plos One 3
105. Resemann A, Wunderlich D, Rothbauer U, Warscheid B, Leonhardt H, Fuchser J, Kuhlmann K, Suckau D (2010): Top-down de novo protein sequencing of a 13.6 kDa came lid single heavy chain antibody by matrix-assisted laser desorption ionization-time-offlight/time-of-flight mass spectrometry. Analytical Chemistry 82, 3283-3292
106. Reyelt J, Schwarz N, Haag F, Goldbaum F, Koch-Nolte F (2006): Manipulating the signaling functions of extracellular NAD with recombinant 'nanobodies' that block the active site of a leucocyte cell surface ectoenzyme. Molecular Medicine 12, S21-S22
107. Romer T, Leonhardt H, Rothbauer U (2011): Engineering antibodies and proteins for molecular in vivo imaging. Current Opinion in Biotechnology 22, 882-887
108. Roovers RC, van Dongen GAMS, Henegouwen PMPV (2007): Nanobodies in therapeutic applications. Current Opinion in Molecular Therapeutics 9, 327-335
109. Roovers RC, Vosjan MJWD, Laeremans T, el Khoulati R, de Bruin RCG, Ferguson KM, Verkleij AJ, van Dongen GAMS, Henegouwen PMPV (2011): A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth. International Journal of Cancer 129, 2013-2024
110. Rutgers KS, Nabuurs RJA, van den Berg SAA, Schenk GJ, Rotman M, Verrips CT, van Duinen SG, Maat-Schieman ML, van Buchem MA, de Boer AG, van der Maarel SM (2011): Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood-brain barrier. Neuroscience 190, 37-42
111. Ryckaert S, Pardon E, Steyaert J, Callewaert N (2010): Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris. Journal of Biotechnology 145, 93-98
112. Saccodossi N, De Simone EA, Leoni J (2012): Structural analysis of effector functions related motifs, complement activation and hemagglutinating activities in Lama glama heavy chain antibodies. Veterinary Immunology and Immunopathology 145, 323-331
113. Saerens D, Muyldermans S (eds.) (2012): Single Domain Antibodies. Springer, New York. 580 pp. http://www.springer. com/biomed/immunology/book/978-1-61779-967-9
114. Saerens D, Pellis M, Loris R, Pardon E, Dumoulin M, Matagne A, Wyns L, Muyldermans S, Conrath K (2005): Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. Journal of Molecular Biology 352, 597-607
115. Saerens D, Ghassabeh GH, Muyldermans S (2008): Single-domain antibodies as building blocks for novel therapeutics. Current Opinion in Pharmacology 8, 600-608
116. Schmidthals K, Helma J, Zolghadr K, Rothbauer U, Leonhardt H (2010): Novel antibody derivatives for proteome and high-content analysis. Analytical and Bioanalytical Chemistry 397, 3203-3208
117. Serruys B, Van Houtte F, Farhoudi-Moghadam A, Leroux-Roels G, Vanlandschoot P (2010): Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies. Journal of General Virology 91, 643-652
118. Simmons DP, Streltsov VA, Dolezal O, Hudson PJ, Coley AM, Foley M, Proll DF, Nuttall SD (2008): Shark Ig-NAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures. Proteins-Structure Function and Bioinformatics 71, 119-130
119. Sircar A, Sanni KA, Shi JY, Gray JJ (2011): Analysis and modeling of the variable region of camelid single-domain antibodies. Journal of Immunology 186, 6357-6367
120. Smith LE, Crouch K, Cao W, Muller MR, Wu LY, Steven J, Lee M, Liang MS, Flajnik MF, Shih HH, Barelle CJ, Paulsen J, Gill DS, Dooley H (2012): Characterization of the immunoglobulin repertoire of the spiny dogfish (Squalus acanthias). Developmental and Comparative Immunology 36, 665-679
121. Smolarek D, Hattab C, Hassanzadeh-Ghassabeh G, Cochet S, Gutierrez C, de Brevern AG, Udomsangpetch R, Picot J, Grodecka M, Wasniowska K, Muyldermans S, Colin Y, Le Van Kim C, Czerwinski M, Bertrand O (2010): A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines. Cellular and Molecular Life Sciences 67, 3371-3387
122. Spinelli S, Tegoni M, Frenken L, van Vliet C, Cambillau C (2001): Lateral recognition of a dye hapten by a llama VHH domain. Journal of Molecular Biology 311, 123-129
123. Stijlemans B, Conrath K, Cortez-Retamozo V, Van Xong H, Wyns L, Senter P, Revets H, De Baetselier P, Muyldermans S, Magez S (2004): Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies-African trypanosomes as paradigm. Journal of Biological Chemistry 279, 1256-1261
124. Stijlemans B, Caljon G, Natesan SKA, Saerens D, Conrath K, Perez-Morga D, Skepper JN, Nikolaou A, Brys L, Pays E, Magez S, Field MC, De Baetselier P, Muyldermans S (2011): High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis. Plos Pathogens 7
125. Stone E, Hirama T, Tanha J, Tong-Sevinc H, Li SH, Mac-Kenzie CR, Zhang JB (2007): The assembly of single domain antibodies into bispecific decavalent molecules. Journal of Immunological Methods 318, 88-94
126. Streltsov VA, Carmichael JA, Nuttall SD (2005): Structure of a shark IgNAR antibody variable domain and modeling of an early-developmental isotype. Protein Science 14, 2901-2909
127. Strokappe N, Szynol A, Aasa-Chapman M, Gorlani A, Quigley AF, Hulsik DL, Chen L, Weiss R, de Haard H, Verrips T (2012): Llama Antibody Fragments Recognizing Various Epitopes of the CD4bs Neutralize a Broad Range of HIV-1 Subtypes A, B and C. Plos One 7
128. Sukhanova A, Even-Desrumeaux K, Kisserli A, Tabary T, Reveil B, Millot JM, Chames P, Baty D, Artemyev M, Oleinikov V, Pluot M, Cohen JHM, Nabiev I (2012): Oriented conjugates of single-domain antibodies and quantum dots: toward a new generation of ultrasmall diagnostic nanoprobes. Nanomedicine-Nanotechnology Biology and Medicine 8, 516-525
129. Swain MD, Anderson GP, Zabetakis D, Bernstein RD, Liu JL, Sherwood LJ, Hayhurst A, Goldman ER (2010): Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin. Analytical and Bioanalytical Chemistry 398, 339-348
130. Swain MD, Anderson GP, Serrano-Gonzalez J, Liu JL, Zabetakis D, Goldman ER (2011): Immunodiagnostic reagents using llama single domain antibody-alkaline phosphatase fusion proteins. Analytical Biochemistry 417, 188-194
131. Szynol A, de Soet JJ, Sieben-van Tuyl E, Bos JW, Frenken LG (2004): Bactericidal effects of a fusion protein of llama heavy-chain antibodies coupled to glucose oxidase on oral bacteria. Antimicrobial Agents and Chemotherapy 48, 3390-3395
132. Tabares-da Rosa S, Rossotti M, Carleiza C, Carrion F, Pritsch O, Ahn KC, Last JA, Hammock BD, Gonzalez-Sapienza G (2011): Competitive selection from single domain antibody libraries allows isolation of high-affinity antihapten antibodies that are not favored in the llama immune response. Analytical Chemistry 83, 7213-7220
133. Talelli M, Iman M, Rijcken CJF, van Nostrum CF, Hennink WE (2010): Targeted core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Journal of Controlled Release 148, E121-E122
134. Talelli M, Rijcken CJF, Oliveira S, van der Meel R, Henegouwen PMPV, Lammers T, van Nostrum CF, Storm G, Hennink WE (2011): Nanobody-shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting. Journal of Controlled Release 151, 183-192
135. Tayebi M, Taylor WA, Jones DR, Bate C, David M (2010): PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein. Journal of General Virology 91, 2121-2131
136. Teh YHA, Kavanagh TA (2010): High-level expression of camelid nanobodies in Nicotiana benthamiana. Transgenic Research 19, 575-586
137. Tillib SV (2011): "Camel nanoantibody"is an efficient tool for research, diagnostics and therapy. Molecular Biology 45, 66-73
138. Torigoe T, Asanuma H, Nakazawa E, Tamura Y, Hirohashi Y, Yamamoto E, Kanaseki T, Hasegawa T, Sato N (2012): Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: Unusually high frequency of down-regulation in breast cancer tissues. Pathology International 62, 303-308
139. Tremblay JM, Kuo CL, Abeijon C, Sepulveda J, Oyler G, Hu XB, Jin MM, Shoemaker CB (2010): Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases. Toxicon 56, 990-998
140. Trilling AK, de Ronde H, Noteboom L, van Houwelingen A, Roelse M, Srivastava SK, Haasnoot W, Jongsma MA, Kolk A, Zuilhof H, Beekwilder J (2011): A broad set of different llama antibodies specific for a 16 kDa heat shock protein of Mycobacterium tuberculosis. Plos One 6
141. Udata C, Mukherjee A, Hutmacher M, Peterson M, Liao KH, Checchio T, Shields K, Meng X, Comer G (2011): Pharmacokinetic-pharmacodynamic modeling of ozoralizumab (ATN-103), a novel humanized nanobody tumor necrosis factor inhibitor for rheumatoid arthritis. Arthritis and Rheumatism 63, S493
142. Van Bockstaele F, Holz JB, Revets H (2009): The development of nanobodies for therapeutic applications. Current Opinion in Investigational Drugs 10, 1212-1224
143. Van de Broek B, Devoogdt N, D'Hollander A, Gijs HL, Jans K, Lagae L, Muyldermans S, Maes G, Borghs G (2011): Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano 5, 4319-4328
144. Vandenbroucke K, de Haard H, Beirnaert E, Dreier T, Lauwereys M, Huyck L, Van Huysse J, Demetter P, Steidler L, Remaut E, Cuvelier C, Rottiers P (2010): Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunology 3, 49-56
145. Vaneycken I, Govaert J, Vincke C, Caveliers V, Lahoutte T, De Baetselier P, Raes G, Bossuyt A, Muyldermans S, Devoogdt N (2010): In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using Pinhole SPECT/Micro-CT. Journal of Nuclear Medicine 51, 1099-1106
146. Vaneycken I, D'Huyvetter M, Hernot S, De Vos J, Xavier C, Devoogdt N, Caveliers V, Lahoutte T (2011a): Immuno-imaging using nanobodies. Current Opinion in Biotechnology 22, 877-881
147. Vaneycken I, Devoogdt N, Van Gassen N, Vincke C, Xavier C, Wernery U, Muyldermans S, Lahoutte T, Caveliers V (2011b): Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer. FASEB Journal 25, 2433-2446
148. Vanlandschoot P, Stortelers C, Beirnaert E, Ibanez LI, Schepens B, Depla E, Saelens X (2011): Nanobodies (R): New ammunition to battle viruses. Antiviral Research 92, 389-407
149. Veggiani G, de Marco A (2011): Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidase. Protein Expression and Purification 79, 111-114
150. Vercruysse T, Pardon E, Vanstreels E, Steyaert J, Daelemans D (2010): An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 Rev prevents viral production. Journal of Biological Chemistry 285, 21768-21780
151. Vincke C, Loris R, Saerens D, Martinez-Rodriguez S, Muyldermans S, Conrath K (2009): General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. Journal of Biological Chemistry 284, 3273-3284
152. Vuchelen A, O'Day E, De Genst E, Pardon E, Wyns L, Dumoulin M, Dobson CM, Christodoulou J, Hsu STD (2009): H-1, C-13 and N-15 assignments of a camelid nanobody directed against human alpha-synuclein. Biomolecular NMR Assignments 3, 231-233
153. Walper SA, Anderson GP, Lee PAB, Glaven RH, Liu JL, Bernstein RD, Zabetakis D, Johnson L, Czarnecki JM, Goldman ER (2012): Rugged single domain antibody detection elements for Bacillus anthracis spores and vegetative Cells. Plos One 7
154. Walsh R, Nuttall S, Revill P, Colledge D, Cabuang L, Soppe S, Dolezal O, Griffiths K, Bartholomeusz A, Locarnini S (2011): Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody. Virology 411, 132-141
155. Wei GW, Meng WX, Guo HJ, Pan WQ, Liu JS, Peng T, Chen L, Chen CY (2011): Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein. Plos One 6
156. Wernery U (2001): Camelid immunoglobulins and their importance for the new-born-A review. Journal of Veterinary Medicine Series B-Infectious Diseases and Veterinary Public Health 48, 561-568
157. Wesolowski J, Alzogaray V, Reyelt J, Unger M, Juarez K, Urrutia M, CauerhffA, Danquah W, Rissiek B, Scheuplein F, Schwarz N, Adriouch S, Boyer O, Seman M, Licea A, Serreze DV, Goldbaum FA, Haag F, Koch-Nolte F (2009): Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Medical Microbiology and Immunology 198, 157-174
158. Yau KYF, Groves MAT, Li SH, Sheedy C, Lee H, Tanha J, MacKenzie CR, Jermutus L, Hall JC (2003): Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library. Journal of Immunological Methods 281, 161-175
159. Zabeau L, Verhee A, Catteeuw D, Faes L, Seeuws S, Decruy T, Elewaut D, Peelman F, Tavernier J (2012): Selection of non-competitive leptin antagonists using a random nanobody-based approach. Biochemical Journal 441, 425-434
160. Zhang JB, Tanha J, Hirama T, Khieu NH, To R, Hong TS, Stone E, Brisson JR, MacKenzie CR (2004): Pentamerization of single-domain antibodies from phage libraries: A novel strategy for the rapid generation of high-avidity antibody reagents. Journal of Molecular Biology 335, 49-56
161. Zou XG, Smith JA, Nguyen VK, Ren LM, Luyten K, Muyldermans S, Bruggemann M (2005): Expression of a dromedary heavy chain-only antibody and B cell development in the mouse. Journal of Immunology 175, 3769-3779